Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association between several subtypes of anxiety disorders and various cortisol indicators in a large cohort study. Anxiety disorders have been suggested to be linked to hypothalamic-pituitary-adrenal (HPA) axis activity, although results are scarce and inconsistent. No earlier studies have examined consistency of HPA axis findings across several anxiety subtypes and whether associations are state or trait dependent. METHODS: Data are derived from 1427 participants of the Netherlands Study of Depression and Anxiety. Three groups were compared: 342 control participants without psychiatric disorders; 311 persons with a remitted (no current) anxiety disorder (social phobia, generalized anxiety disorder, panic disorder); and 774 persons with a current anxiety disorder, as diagnosed using the Composite International Diagnostic Interview psychiatric interview. Cortisol levels were measured in seven saliva samples, determining the 1-hour cortisol awakening response, evening cortisol, and cortisol response after 0.5 mg of dexamethasone ingestion. RESULTS: Current anxiety disorder was associated with higher awakening cortisol levels (p = .002). These findings were mainly present for patients with panic disorder with agoraphobia and anxious patients with comorbid depressive disorder. Remitted anxiety only showed a trend toward higher morning cortisol (p = .08). No associations were observed for anxiety status and evening cortisol level or cortisol suppression after dexamethasone. CONCLUSIONS: This study showed a modest but significantly higher 1-hour cortisol awakening response among anxiety patients, which was driven by those with panic disorder with agoraphobia and those with comorbid depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher cortisol awaking response has been described in individuals with PD with agoraphobia (Vreeburg et al, 2010)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vreeburg et al, 2010
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“in 1000 MET-minutes (metabolic energy turnover per minute) a week (34).”
BackgroundAn inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 8×
“severity, the 21-item BAI (35) was used.”
InfluentialStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · cited 1×
“A nxiety disorders can be precipitated and accompanied by stress (1) and may, therefore, be associated with hypothalamic-pituitary-adrenal (HPA) axis dysregulation (2).”
BackgroundPruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00108-7 · Cited by 3,638 · cited 1×
“to the ground (AUCg), using Pruessner’s formulas (31).”
MethodCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243 · cited 1×
“This test provides information on the negative feedback system of the HPA axis, because dexamethasone reduces cortisol level by acting on the pituitary (33).”
BackgroundSalivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801 · cited 1×
“the 15-item Fear Questionnaire was used (36).”
Salivary Cortisol in Psychobiological Research: An Overview
Kirschbaum, C., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000118611 · Cited by 1,532 · cited 1×
“saliva sampling, reflecting the active unbound form of cortisol (28).”
BackgroundGueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529 · cited 2×
“take correlation between repeated data into account (32).”
BackgroundThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · cited 1×
“Anxiety disorder has—although inconsistently—been linked to increased corticotropin-releasing factor, which stimulates HPA axis activity (6).”
Background
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“Higher cortisol awaking response has been described in individuals with PD with agoraphobia (Vreeburg et al, 2010) and cortisol nonsuppression in response to dexamethasone in those with agoraphobia and PD (Coryell et al, 1989).”
BackgroundReview on Psychological Stress Detection Using Biosignals
Giannakakis, G., Grigoriadis, D., Giannakaki, K., Simantiraki, O., Roniotis, A., & Tsiknakis, M. (2022) · IEEE Transactions on Affective Computing · doi:10.1109/taffc.2019.2927337 · Cited by 764
“The characteristic early morning peak is internally driven occurring prior to awakening with a further increase triggered by exposure to psychological stress in response to awakening [12].”
BackgroundHair cortisol, stress exposure, and mental health in humans: A systematic review
Staufenbiel, S. M., Penninx, B. W. J. H., Spijker, A. T., Elzinga, B. M., & van Rossum, E. F. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.015 · Cited by 736
Self-citationBasomedial amygdala mediates top-down control of anxiety and fear
Adhikari, A., Lerner, T. N., Finkelstein, J., Pak, S., Jennings, J. H., Davidson, T. J., Ferenczi, E., Gunaydin, L. A., Mirzabekov, J. J., Ye, L., et al. (2015) · Nature · doi:10.1038/nature15698 · Cited by 485
Anxiety and new onset of cardiovascular disease: critical review and meta-analysis
Batelaan, N. M., Seldenrijk, A., Bot, M., van Balkom, A. J. L. M., & Penninx, B. W. J. H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156554 · Cited by 362
Self-citationBandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
“Higher CSF 5-HIAA in women with comorbid MDD and lifetime panic disorder was indicative of greater 5-HT release, increased 5-HT metabolism, and/or decreased 5-HIAA clearance in this group.”
BackgroundInfluentialAging and the HPA axis: Stress and resilience in older adults
Gaffey, A. E., Bergeman, C. S., Clark, L. A., & Wirth, M. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.036 · Cited by 273
“…enduring the physiological effects of stress, chronic stress in later life, and normal biological aging could all contribute to age differences in HPA axis activity and enhance susceptibility to health problems (e.g., Abercrombie, 2009; Lupien and McEwen, 1997; Vreeburg et al., 2010; Wolf, 2003).”
BackgroundInfluentialMaternal anxiety and infants’ hippocampal development: timing matters.
Qiu, A., Rifkin-Graboi, A., Chen, H., Chong, Y.-S., Kwek, K., Gluckman, P. D., Fortier, M. V., & Meaney, M. J. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.79 · Cited by 214
Childhood stressful events, HPA axis and anxiety disorders
Faravelli, C. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i1.13 · Cited by 198
ter Meulen, W. G., Draisma, S., van Hemert, A. M., Schoevers, R. A., Kupka, R. W., Beekman, A. T. F., & Penninx, B. W. J. H. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.004 · Cited by 170
Self-citationEarly life stress and cortisol: A meta-analysis
Fogelman, N., & Canli, T. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.12.014 · Cited by 192
Longitudinal association between pain, and depression and anxiety over four years
Gerrits, M. M. J. G., van Marwijk, H. W. J., van Oppen, P., van der Horst, H., & Penninx, B. W. J. H. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.10.011 · Cited by 172
“In depressed and anxious individuals inflammation and hyperactivity of the HPA-axis and autonomic dysregulation have been observed, which have also been linked to chronic pain [4,17,19,20,51,52].”
BackgroundSelf-citationKubala, E., Strzelecka, P., Grzegocka, M., Lietz–Kijak, D., Gronwald, H., Skomro, P., & Kijak, E. (2018) · BioMed Research International · doi:10.1155/2018/6572381 · Cited by 193
“A slight but extremely significant difference was demonstrated in patients suffering from panic attacks with coexistent agoraphobia and depression [76].”
BackgroundBiological markers of generalized anxiety disorder
Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/dnutt · Cited by 164
Kircanski, K., LeMoult, J., Ordaz, S., & Gotlib, I. H. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.006 · Cited by 146
“Individual differences in patterns of diurnal cortisol production have been implicated in the etiology of both depression and anxiety (Herbert, 2013; Stetler and Miller, 2005; Vreeburg et al., 2009, 2010), and are featured prominently in the NIMH RDoC.”
BackgroundHypothalamic‐Pituitary‐Adrenocortical Axis: Neuropsychiatric Aspects
Jacobson, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130036 · Cited by 144
Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W. J. H., PELT, J. V., Spinhoven, P., & Roelofs, K. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.014 · Cited by 159
“Elevated plasma cortisol levels and hyperactivity of CRF neurons in the paraventricular nucleus (PVN) of the hypothalamus are consistent neurobiological findings in depressive and anxiety disorders [17,65,78,79], and the expression of androgen receptors is low in post-mortem brain tissue from patients with depression…”
Self-citationCumulative stress in research animals: Telomere attrition as a biomarker in a welfare context?
Bateson, M. (2016) · BioEssays · doi:10.1002/bies.201500127 · Cited by 140
“Mood disorders Anxiety disorders Cortisol " [70] Inflammation " [71]”
BackgroundKandola, A., & Stubbs, B. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-1792-1_23 · Cited by 140
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Wearable and Implantable Cortisol‐Sensing Electronics for Stress Monitoring
Ok, J., Park, S., Jung, Y. H., & Kim, T. (2023) · Advanced Materials · doi:10.1002/adma.202211595 · Cited by 136
The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression
Dortland, A. K. B. V. R., Vreeburg, S. A., Giltay, E. J., Licht, C. M. M., Vogelzangs, N., van Veen, T., de Geus, E. J. C., Penninx, B. W. J. H., & Zitman, F. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.05.017 · Cited by 135
“Within the NESDA study we previously found that certain biological stress systems and lifestyle factors relate to anxiety, depression and TCA use (Licht et al., 2008, 2009; Vreeburg et al., 2009a, 2010; de Wit et al., 2010), as well as to lipids and obesity (Licht et al., 2010b).”
Self-citationAdam, E. K., Vrshek-Schallhorn, S., Kendall, A. D., Mineka, S., Zinbarg, R. E., & Craske, M. G. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.014 · Cited by 108
“More specifically, in one study individuals with current anxiety disorders (n=774) showed significantly greater CAR values than their remitted (n=311) and never-disordered (n=324) counterparts (Vreeburg et al., 2010).”
Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis
Blay, S. L., Aguiar, J., & Passos, I. C. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s91700 · Cited by 111
“In the latter condition, studies suggest that such dysregulation may be state dependent, as higher cortisol levels can be found in persons with current anxiety disorder and borderline cortisol levels for those with remitted symptoms.(27) The maintenance of basal HPA tone is essential for homeostasis, which is usually…”
Salivary cortisol levels and the 2-year course of depressive and anxiety disorders
Vreeburg, S. A., Hoogendijk, W. J. G., DeRijk, R. H., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.017 · Cited by 121
“In our previous study, we observed that of the subtypes of anxiety disorders only panic disorder with agoraphobia was associated with higher cortisol values (Vreeburg et al., 2010b).”
Self-citationDysregulated physiological stress systems and accelerated cellular aging
Révész, D., Verhoeven, J. E., Milaneschi, Y., de Geus, E. J. C., Wolkowitz, O. M., & Penninx, B. W. J. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.027 · Cited by 127
Self-citationvan Santen, A., Vreeburg, S. A., van der Does, W. A. J., Spinhoven, P., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.014 · Cited by 128
Self-citationAnxiety disorders and salivary cortisol levels in older adults: a population-based study
Hek, K., Direk, N., Newson, R. S., Hofman, A., Hoogendijk, W. J. G., Mulder, C. L., & Tiemeier, H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.06.006 · Cited by 116
“Deregulation of the CAR, and total cortisol secretion over the day have been associated with various disorders, including anxiety disorders (Vreeburg et al., 2010).”
Self-citationFernandez, M., Colodro-Conde, L., Hartvigsen, J., Ferreira, M. L., Refshauge, K. M., Pinheiro, M. B., Ordoñana, J. R., & Ferreira, P. H. (2017) · The Spine Journal · doi:10.1016/j.spinee.2017.02.009 · Cited by 115
Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders
Gerrits, M. M., van Oppen, P., Leone, S. S., van Marwijk, H. W., van der Horst, H. E., & Penninx, B. W. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-187 · Cited by 106
“For instance, HPA-axis abnormalities were found to be strongly associated with depressive disorder and co-morbid depression and anxiety, but were not present for most types of anxiety disorders [52,53].”
BackgroundSelf-citationZhao, W., Zhang, Y., Liu, X., Yue, J., Hou, L., Xia, X., Zuo, Z., Liu, Y., Jia, S., Dong, B., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.070 · Cited by 107
Dimensions of Depression and Anxiety and the Hypothalamo-Pituitary-Adrenal Axis
Wardenaar, K. J., Vreeburg, S. A., van Veen, T., Giltay, E. J., Veen, G., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.005 · Cited by 109
“From this perspective, the present results can be regarded as an elaboration on previous findings of increased morning cortisol in lifetime MDD and anxiety (6,13).”
BackgroundResultSelf-citationBehavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity
Kokras, N., Dalla, C., Sideris, A. C., Dendi, A., Mikail, H. G., Antoniou, K., & Papadopoulou‐Daifoti, Z. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.025 · Cited by 116
“Finally, it should be noted that sex hormones are essentially involved in the female stress and antidepressant response (Estrada-Camarena et al., 2010;Walf and Frye, 2006), aswell as in the presentation of affective disorders in women (Kornstein et al., 2010; Young et al., 2007).”
Penninx, B. W. J. H., Eikelenboom, M., Giltay, E. J., van Hemert, A. M., Riese, H., Schoevers, R. A., & Beekman, A. T. F. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.03.026 · Cited by 115
Self-citationOxytocin and stress-related disorders: neurobiological mechanisms and treatment opportunities
Sippel, L. M., Allington, C. E., Pietrzak, R. H., Harpaz-Rotem, I., Mayes, L. C., & Olff, M. (2017) · Chronic Stress · doi:10.1177/2470547016687996 · Cited by 99
“Both reduced and elevated levels of cortisol have been observed in psychiatric populations, in part due to methodological heterogeneity.(106,107) A meta-analysis of 18 randomized, placebo-controlled IN OT studies revealed a modest, nonsignificant effect size for effects of IN OT on cortisol levels.”
BackgroundParental history of depression or anxiety and the cortisol awakening response
Vreeburg, S. A., Hartman, C. A., Hoogendijk, W. J. G., Dyck, R. V., Zitman, F. G., Ormel, J., & Penninx, B. W. J. H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076869 · Cited by 95
Self-citationBoggero, I. A., Hostinar, C. E., Haak, E. A., Murphy, M. L. M., & Segerstrom, S. C. (2017) · Biological Psychology · doi:10.1016/j.biopsycho.2017.08.058 · Cited by 97
Kahl, K. G., Schweiger, U., Correll, C., Müller, C., Busch, M., Bauer, M., & Schwarz, P. (2015) · Brain and Behavior · doi:10.1002/brb3.306 · Cited by 89
“Similar to findings in major depressive disorder, a dysregulation of cortisol secretion has been found in anxiety disorders (Vreeburg et al. 2010).”
ResultGawali, N. B., Bulani, V. D., Gursahani, M., Deshpande, P. S., Kothavade, P. S., & Juvekar, A. R. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.004 · Cited by 100
Endocannabinoids, cannabinoids and the regulation of anxiety
Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 98
Dietrich, A., Ormel, J., Buitelaar, J. K., Verhulst, F. C., Hoekstra, P. J., & Hartman, C. A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.013 · Cited by 99
“…in higher basal morning cortisol levels or a higher CAR, has been related to anxiety and depressive (internalizing) symptoms not only in adults (Vreeburg et al., 2009, 2010; Knorr et al., 2010; Stetler and Miller, 2011) but also in children and adolescents (Lopez-Duran et al., 2009a; Ruttle et…”
BackgroundFatseas, M., Serre, F., Swendsen, J., & Auriacombe, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.008 · Cited by 89
Salubrious effects of oxytocin on social stress-induced deficits
Smith, A. S., & Wang, Z. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.11.010 · Cited by 88
“In clinical research, individuals with depression, anxiety, fear, and panic disorders often have dysregulated HPA axis activity, raised basal plasma cortisol, and more intense ACTH and cortisol responses to stress (Rothschild et al., 1989; Tse and Bond, 2004; Vreeburg et al., 2009; Vreeburg et al., 2010; reviewed by P…”
BackgroundWijker, C., Leontjevas, R., Spek, A., & Enders-Slegers, M.-J. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-03971-9 · Cited by 75
Generaal, E., Vogelzangs, N., Macfarlane, G. J., Geenen, R., Smit, J. H., Penninx, B. W. J. H., & Dekker, J. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-227 · Cited by 100
“This study found hypoactive HPA-axis function in chronic multi-site musculoskeletal pain (Table 2), while depressive and some types of anxiety disorders have previously been associated with hypercortisolemia [31,32], also in the NESDA study [33,34].”
BackgroundSelf-citationAntidepressant use and salivary cortisol in depressive and anxiety disorders
Manthey, L., Leeds, C., Giltay, E. J., van Veen, T., Vreeburg, S. A., Penninx, B. W. J. H., & Zitman, F. G. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.002 · Cited by 93
Self-citationInteractions between Stress and Vestibular Compensation – A Review
Saman, Y., Bamiou, D., Gleeson, M. J., & Dutia, M. B. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00116 · Cited by 95
“Vreeburg et al. (2010) demonstrated in a cross-sectional study using a large cohort that anxiety, in particular panic disorder, was associated with increased levels of cortisol (Vreeburg et al., 2010), which reinforces the positive-feedback cycle suggested above.”
Lahti, M., Eriksson, J. G., Heinonen, K., Kajantie, E., Lahti, J., Wahlbeck, K., Tuovinen, S., Pesonen, A.-K., Mikkonen, M., Osmond, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291714001998 · Cited by 77
Ouellette, S. J., Russell, E., Kryski, K. R., Sheikh, H. I., Singh, S. M., Koren, G., & Hayden, E. P. (2015) · Developmental Psychobiology · doi:10.1002/dev.21302 · Cited by 86
“…research has linked salivary cortisol reactivity to children’s symptoms of psychopathology (Adam et al., 2010; Bhagwagar et al., 2005; Nemeroff & Vale, 2005; Vreeburg et al., 2009, 2010), including our own group’s previous work with the current sample (Kryski, Smith, Sheikh, Singh, & Hayden, 2013).”
ResultThe incidence of stress symptoms and heart rate variability during sleep and orthostatic test
Hynynen, E., Konttinen, N., Kinnunen, U. M., Kyröläinen, H., & Rusko, H. K. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1698-x · Cited by 107
“Especially awakening response in saliva cortisol has been found to be positively related to anxiety (Vreeburg et al. 2010) and job strain (Maina et al.”
BackgroundLong-term cortisol in bipolar disorder: Associations with age of onset and psychiatric co-morbidity
Manenschijn, L., Spijker, A. T., Koper, J. W., Jetten, A. M., Giltay, E. J., Haffmans, J., Hoencamp, E., & van Rossum, E. F. C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.010 · Cited by 76
“Reports of saliva, serum and urine cortisol levels in patients with panic disorder have shown conflicting results (Kathol et al., 1989; Yehuda et al., 1993; Bandelow et al., 2000a,b; Wedekind et al., 2000; Vreeburg et al., 2010), which emphasizes the need for a new reliable measurement of long-term cortisol exposure.”
ResultPsychological pathways from racial discrimination to cortisol in African American males and females
Lee, D. B., Peckins, M. K., Heinze, J. E., Miller, A. L., Assari, S., & Zimmerman, M. A. (2017) · Journal of Behavioral Medicine · doi:10.1007/s10865-017-9887-2 · Cited by 79
“…USA 2 Department of Psychology, University of Michigan, Ann Arbor, MI, USA 3 Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA logical functioning as a potential pathway of influence (e.g., anxiety; Vreeburg et al., 2010).”
Investigation of Cortisol Levels in Patients with Anxiety Disorders: A Structured Review
Elnazer, H. Y., & Baldwin, D. S. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_299 · Cited by 81
LeMoult, J., Ordaz, S. J., Kircanski, K., Singh, M. K., & Gotlib, I. H. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000087 · Cited by 72
“Extant data clearly demonstrate that HPA-axis functioning is influenced both by a history of depression (e.g., LeMoult et al., 2015) and by a diagnosis of a current or past anxiety disorder (e.g., Vreeburg et al., 2010; Mantella et al., 2010).”
BackgroundAnxiety disorders and accelerated cellular ageing
Verhoeven, J. E., Révész, D., van Oppen, P., Epel, E. S., Wolkowitz, O. M., & Penninx, B. W. J. H. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.151027 · Cited by 67
Self-citationHair cortisol: A new tool for evaluating stress in programs of stress management
Iglesias, S. L., Jacobsen, D., González, D., Azzara, S. H., Repetto, E. M., Jamardo, J., Gómez, S. G., Mesch, V., Berg, G. A., & Fabre, B. R. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.006 · Cited by 74
Harmful effects of functional hypercortisolism: a working hypothesis
Tirabassi, G., Boscaro, M., & Arnaldi, G. (2013) · Endocrine · doi:10.1007/s12020-013-0112-y · Cited by 77
The effects of music & auditory beat stimulation on anxiety: A randomized clinical trial
Mallik, A., & Russo, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0259312 · Cited by 75
“Indeed, higher cortisol levels are pres-ent in people suffering from anxiety disorders [7,8].”
Hankin, B. L., Badanes, L. S., Smolen, A., & Young, J. F. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000030 · Cited by 56
“…use problems in adults and youth (Burke, Davis, Otte, & Mohr, 2005; Gunnar & Quevedo, 2007; Gunnar & Vazquez, 2006; Lopez-Duran, Kovacs, & George, 2009; Schepis, Rao, Yadav, & Adinoff, 2011; Schiefelbein & Susman, 2006; Vreeburg et al., 2010; Walker et al., 2001; Walker, Sabuwalla, & Huot, 2004).”
Mind and body: how the health of the body impacts on neuropsychiatry
Renoir, T., Hasebe, K., & Gray, L. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00158 · Cited by 71
“Those modest but significant differences were also observed in patients with anxiety disorders (Vreeburg et al., 2010).”
BackgroundThe Impact of Stress on Odor Perception
Hoenen, M., Wolf, O. T., & Pause, B. M. (2017) · Perception · doi:10.1177/0301006616688707 · Cited by 68
“In addition, anxious personality traits, which are associated with increased cortisol levels (Vreeburg et al., 2010), are associated with better odor discrimination abilities (Havlı́ček et al.”
BackgroundDecreased hypothalamus volumes in generalized anxiety disorder but not in panic disorder
Terlević, R., Isola, M., Ragogna, M., Meduri, M., Canalaz, F., Perini, L., Rambaldelli, G., Travan, L., Crivellato, E., Tognin, S., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.024 · Cited by 64
“Vreeburg et al. (2010) have found normal morning and evening cortisol levels in GAD patients without comorbidities, but an increase in GAD with comorbid depression.”
BackgroundSalivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
Djamshidian, A., O'Sullivan, S. S., Papadopoulos, A., Bassett, P., Shaw, K., Averbeck, B. B., & Lees, A. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.245746 · Cited by 55
Long-term glucocorticoid levels measured in hair in patients with depressive and anxiety disorders
Gerritsen, L., Staufenbiel, S. M., Penninx, B. W. J. H., van Hemert, A. M., Noppe, G., de Rijke, Y. B., & van Rossum, E. F. C. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.019 · Cited by 53
Self-citationDepressive and anxiety disorders and risk of subclinical atherosclerosis
Seldenrijk, A., Vogelzangs, N., van Hout, H. P. J., van Marwijk, H., Diamant, M., & Penninx, B. W. J. H. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.01.005 · Cited by 60
“Indeed, especially for depression, higher circulating inflammatory marker levels [7,40] and a higher cortisol awakening response [41,42] has been found.”
BackgroundSelf-citationGupta, D., Radhakrishnan, M., & Kurhe, Y. (2015) · Steroids · doi:10.1016/j.steroids.2015.01.021 · Cited by 60
Blay, S. L., & Marinho, V. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283578cdd · Cited by 48
“In the latter condition, studies suggest that such dysregulation may be state dependent, as higher cortisol levels can be found in persons with current anxiety disorder and borderline cortisol levels for those with remitted symptoms [33].”
BackgroundCordero, M. J. A., Sánchez-López, A. M., Villar, N. M., García, I. G., López, M. A. R., Piñero, A. O., & Cortés-Castell, E. (2014) · PubMed · doi:10.3305/nh.2014.29.5.7273 · Cited by 96
Farajdokht, F., Babri, S., Karimi, P., Alipour, M. R., Bughchechi, R., & Mohaddes, G. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13486 · Cited by 56
“, 2010) and previous studies also demonstrated that anxiety is associated with elevated cortisol levels (Chaudieu et al., 2008; Mantella et al., 2008; Vreeburg et al., 2010).”
BackgroundLoneliness in older adults is associated with diminished cortisol output
Schutter, N., Holwerda, T. J., Stek, M. L., Dekker, J., Rhebergen, D., & Comijs, H. C. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.02.002 · Cited by 60
Jindal, A., Mahesh, R., & Bhatt, S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.005 · Cited by 54
Biosensors for psychiatric biomarkers in mental health monitoring
Wang, L., Hu, Y., Jiang, N., & Yetisen, A. K. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116242 · Cited by 54
Dietary Patterns and Their Association with Anxiety Symptoms among Older Adults: The ATTICA Study
Masana, M. F., Tyrovolas, S., Kollia, N., Chrysohoou, C. A., Skoumas, J., Haro, J. M., Tousoulis, D. M., Papageorgiou, C., Pitsavos, C. S., & Panagiotakos, D. B. (2019) · Nutrients · doi:10.3390/nu11061250 · Cited by 58
“Smoking have been reported to activate the HPA axis increasing adrenocorticotropic hormone (ACTH) and cortisol [45], which have been related with anxiety [46].”
BackgroundPsychotropic medication effects on cortisol: Implications for research and mechanisms of drug action
Subramaniam, A., LoPilato, A. M., & Walker, E. F. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.023 · Cited by 51
Wang, W., Feng, J., Ji, C., Mu, X., Ma, Q., Fan, Y., Chen, C., Gao, C., Ma, X.-C., & Zhu, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.01.019 · Cited by 49
“The elevated levels of morning basal serum cortisol in patients with GAD in our study, the high awakening cortisol levels in patients with current anxiety (Vreeburg et al., 2010), and the recovery of elevated cortisol levels in GAD after antianxiety therapy (Lenze et al.”
BackgroundResultInfluentialLeme, M., Barbosa, T. D. S., Castelo, P. M., & Gavião, M. (2014) · Journal of Clinical Pediatric Dentistry · doi:10.17796/jcpd.38.4.c48238322205466w · Cited by 48
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview
Vismara, M., Girone, N., Cirnigliaro, G., Fasciana, F., Vanzetto, S., Ferrara, L., Priori, A., D’Addario, C., Viganò, C., & Dell’Osso, B. (2020) · Brain Sciences · doi:10.3390/brainsci10080564 · Cited by 46
Ludmer, J. A., González, A., Kennedy, J. L., Masellis, M., Meinz, P., & Atkinson, L. R. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.04.006 · Cited by 52
Wang, L. A., de Kloet, A. D., Smeltzer, M. D., Cahill, K. M., Hiller, H., Bruce, E. B., Pioquinto, D. J., Ludin, J. A., Katovich, M. J., Raizada, M. K., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.025 · Cited by 45
“Anxiety disorders are associated with HPA axis dysfunction (Abelson et al., 2007; Brand et al., 2011; Vreeburg et al., 2010) and we discovered that the majority of CRH neurons in the PVN express AT1aR(s) and their deletion down-regulates CRH mRNA (de Kloet et al., 2013; de Kloet et al., 2017;Wang…”
InfluentialMadsen, K. S., Jernigan, T. L., Iversen, P., Frøkjær, V. G., Mortensen, E. L., Knudsen, G. M., & Baaré, W. F. C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.015 · Cited by 46
“Disruption of the diurnal profile of the HPA axis has been found in psychiatric disorders, such as posttraumatic stress disorder (PTSD) (Chida and Steptoe, 2009), anxiety disorder (Vreeburg et al., 2010) and major depression (Chida and Steptoe, 2009; Vreeburg et al.”
BackgroundValsamakis, G., Papatheodorou, D. C., Chalarakis, N., Vrachnis, N., Sidiropoulou, E. J., Manolikaki, M., Mantzou, A., Margeli, A., Papassotiriou, I., Chrousos, G. P., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.008 · Cited by 46
Chen, F. R., Raine, A., & Granger, D. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.027 · Cited by 47
Doron, R., Lotan, D., Versano, Z., Benatav, L., Franko, M., Armoza, S., Kately, N., & Rehavi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091455 · Cited by 42
“Abnormalities in the HPA axis functioning have been repeatedly documented in patients suffering from anxiety disorders [39,40].”
BackgroundBiological Markers of Generalized Anxiety Disorder
Maron, E., & Nutt, D. (2018) · Focus · doi:10.1176/appi.focus.16205 · Cited by 42
Brain-Wide Mendelian Randomization Study of Anxiety Disorders and Symptoms
Zanoaga, M. D., Friligkou, E., He, J., Pathak, G. A., Koller, D., Cabrera‐Mendoza, B., Stein, M. B., & Polimanti, R. A. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.11.006 · Cited by 58
A biological measure of stress levels in patients with functional movement disorders
Maurer, C. W., LaFaver, K., Ameli, R., Toledo, R., & Hallett, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.017 · Cited by 39
“The elevated morning cortisol seen in patients with anxiety has previously been demonstrated to be driven primarily by patients with panic disorder with agoraphobia[19].”
BackgroundChen, F. R., Raine, A., Soyfer, L., & Granger, D. A. (2014) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-014-9900-y · Cited by 42
“Some observed increased cortisol activity (Vreeburg et al. 2010; Wedekind et al. 2000) while some found normal cortisol activity (Gurguis, Mefford, and Uhde 1991).”
BackgroundCorominas, M., Ramos‐Quiroga, J. A., Ferrer, M., Sáez‐Francàs, N., Palomar, G., Bosch, R., & Casas, M. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0075-5 · Cited by 47
Is anxious-depression an inflammatory state?
Camacho, Á. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.006 · Cited by 39
“depression, the central nervous system and systemic inflammatory response [31].”
BackgroundAttention-deficit/hyperactivity disorder symptoms and stress-related biomarkers
Vogel, S. W. N., Bijlenga, D., Verduijn, J., Bron, T. I., Beekman, A. T. F., Kooij, J. J. S., & Penninx, B. W. J. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.02.009 · Cited by 40
Self-citationvan der Voorn, B., Hollanders, J. J., Kieviet, N., Dolman, K. M., de Rijke, Y. B., van Rossum, E. F. C., Rotteveel, J., Honig, A., & Finken, M. J. J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000495007 · Cited by 39
Human defensive freezing: Associations with hair cortisol and trait anxiety
Hashemi, M. M., Zhang, W., Kaldewaij, R., Koch, S. B. J., Smit, A. S., Figner, B., Jonker, R., Klumpers, F., & Roelofs, K. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105417 · Cited by 44
A Place for Sexual Dysfunctions in an Empirical Taxonomy of Psychopathology
Forbes, M. K., Baillie, A., Eaton, N. R., & Krueger, R. F. (2017) · The Journal of Sex Research · doi:10.1080/00224499.2016.1269306 · Cited by 40
“In short, all of the neural substrates mentioned here have a prominent role in internalizing disorders as well as sexual function (Goldberg, Krueger, Andrews, & Hobbs, 2009; Hirschfeld, 2000; Levine, 2000; Pariante & Lightman, 2008; Stein, Westenberg, & Liebowitz, 2002; Vaidyanathan, Patrick, & Cuthbert, 2009; Vreebur…”
BackgroundThe adrenal gland microenvironment in health, disease and during regeneration
Kanczkowski, W., Sue, M., & Bornstein, S. R. (2017) · HORMONES · doi:10.14310/horm.2002.1744 · Cited by 41
Yadavalli, C. S., Kumar, G. P., Navya, K., Ramya, E. M., & Anilakumar, K. R. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13007 · Cited by 38
“In previous studies, an increased concentration of serum cortisol was observed in anxiety patients.([37]) In the present observations, PTX had induced hyperactivation of HPA through Figure 4 Antioxidants and biochemical parameters in serum cortisol.”
BackgroundBottaccioli, F., Carosella, A., Cardone, R., Mambelli, M., Cemin, M., D’Errico, M. M., Ponzio, E., Bottaccioli, A. G., & Minelli, A. (2014) · EXPLORE · doi:10.1016/j.explore.2014.02.002 · Cited by 40
Cortisol sensing by optical sensors
Santonocito, R., Puglisi, R., Cavallaro, A., Pappalardo, A., & Sfrazzetto, G. T. (2023) · The Analyst · doi:10.1039/d3an01801f · Cited by 34
Ali, N., Nitschke, J. P., Cooperman, C., Baldwin, M. W., & Pruessner, J. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0726-8 · Cited by 37
Emotional suppression in chronic fatigue syndrome: Experimental study.
Rimes, K. A., Ashcroft, J., Bryan, L., & Chalder, T. (2016) · Health Psychology · doi:10.1037/hea0000341 · Cited by 37
Jindal, A., Mahesh, R., & Bhatt, S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.017 · Cited by 38
Metadata
- Authors
- Vreeburg, S. A., Zitman, F. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Hoogendijk, W. J. G., Smit, J. H., & Penninx, B. W. J. H.
- Affiliations
- Amsterdam Public Health (NL)
- University Medical Center Groningen (NL)
- Corresponding author
- Vreeburg, Sophie A.
- Venue
- Psychosomatic Medicine
- Published
- 2010-05
- Volume
- 72
- Issue
- 4
- Pages
- 340-347
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2096838333
- Cited by
- 312
- References
- 49
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 15 · 2020: 17 · 2019: 23 · 2018: 21 · 2017: 23 · 2016: 19 · 2015: 24 · 2014: 25 · 2013: 23 · 2012: 22
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- VU Research Portal (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- anxiety disorders, salivary cortisol, cortisol awakening response, hypothalamic-pituitary-adrenal axis, panic disorder with agoraphobia, generalized anxiety disorder, social anxiety disorder, dexamethasone suppression, comorbid depression
- MeSH terms
- Adult, Agoraphobia, Anxiety Disorders, Circadian Rhythm, Major Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Personality Inventory, Phobic Disorders, Pituitary-Adrenal System, Saliva, Seasons, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.